Pregabalin

Pregabalin was invented by Richard Bruce Silverman in the United States of America to replace Gabapentin. Pregabalin is used for the treatment of neuropathic pain, partial seizures and generalized anxiety disorders. It is also used to treat fibromyalgia in the USA and is listed as one of the top 30 prescribed medications. Pregabalin is eliminated from the systemic circulation primarily by renal excretion as unchanged drug with a mean half-life of 6.3 hours in subjects with normal renal function. The side effects of pregabalin can include asthenia, dry mouth, constipation, peripheral edema, dizziness, somnolence, confusion and blurred vision. Serious side effects include sedation, respiratory failure and death.

Whole Blood
Post Mortem Blood
Urine
Oral Fluid
Hair
Meconium
Vitreous Humor
Tissue

Cross Reactivity

Analyte Compound
Cross Reactivity %
CR%
Pregabilin
LOD: 0.159 µg/mL
Pregabalin 100
DMAA
2.2
Gabapentin
<1

All data in the above table refers to our whole blood matrix.

Microplate Readers Available

Product ds2 7

DS2

  • Fully automated compact reader
  • Processes 100 samples per run
  • Ideal for routine drug detection


Product elx800 cutout tox logo

ELx800

  • Semi-automated robust microplate reader
  • Reads 96 wells in 30 seconds
  • Ideal for routine drug detection

UK: +44 (0)28 9442 2413
USA: +1 304 728 2890